What is Corinthian Reference Lab?
Corinthian Reference Lab is a commercial diagnostic laboratory focused on identifying neurological diseases, with a particular emphasis on small fiber neuropathy testing. The company provides epidermal nerve fiber density (ENFD) testing, offering objective evidence to physicians for diagnosing underlying neuropathy causes. CRL facilitates the ordering of test kits and online payments, aiming to accurately diagnose small fiber peripheral neuropathy, often linked to conditions like diabetes.
How much funding has Corinthian Reference Lab raised?
Corinthian Reference Lab has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Corinthian Reference Lab?
The substantial late-stage funding indicates a period of significant scaling and market penetration for Corinthian Reference Lab. This capital injection is likely to fuel advancements in diagnostic technology, expansion of testing capabilities, and broader outreach to medical practitioners. The company's strategic focus on objective diagnostic evidence for complex conditions positions it for continued growth and influence within the specialized diagnostics market.
See full Corinthian Reference Lab company page
